0001144204-19-005050.txt : 20190205
0001144204-19-005050.hdr.sgml : 20190205
20190205163917
ACCESSION NUMBER: 0001144204-19-005050
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190201
FILED AS OF DATE: 20190205
DATE AS OF CHANGE: 20190205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Greenleaf Peter
CENTRAL INDEX KEY: 0001363683
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36672
FILM NUMBER: 19568462
MAIL ADDRESS:
STREET 1: ONE MEDIMMUNE WAY
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EYEGATE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001372514
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 271 WAVERLEY OAKS ROAD
STREET 2: SUITE 108
CITY: WALTHAM
STATE: MA
ZIP: 02452
BUSINESS PHONE: 781-788-9043
MAIL ADDRESS:
STREET 1: 271 WAVERLEY OAKS ROAD
STREET 2: SUITE 108
CITY: WALTHAM
STATE: MA
ZIP: 02452
4
1
tv512448_form4.xml
FORM 4
X0306
4
2019-02-01
0
0001372514
EYEGATE PHARMACEUTICALS INC
EYEG
0001363683
Greenleaf Peter
C/O EYEGATE PHARMACEUTICALS, INC.
271 WAVERLEY OAKS ROAD, SUITE 108
WALTHAM
MA
02452
1
0
0
0
Stock Option (right to buy)
0.48
2019-02-01
4
A
0
50000
0
A
2029-02-01
Common Stock
50000
50000
D
The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to 100% of the shares underlying the Option on February 1, 2020.
/s/ Robert A. Petitt, Attorney-in-Fact, Signed under power of attorney on behalf of Reporting Person
2019-02-05